This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Registry and Prevalence of Gene Mutation in Korean Patients With Familial Hypertrophic Cardiomyopathy

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Yonsei University
ClinicalTrials.gov Identifier:
NCT01792960
First received: February 7, 2013
Last updated: February 17, 2014
Last verified: February 2014
February 7, 2013
February 17, 2014
February 2013
August 2013   (Final data collection date for primary outcome measure)
1) DNA analysis [ Time Frame: 1 year ]
1) Identify susceptible genes for familial hypertrophic cardiomyopathy in Korean
Same as current
Complete list of historical versions of study NCT01792960 on ClinicalTrials.gov Archive Site
2) Prognosis of familial hypertrophic cariomyopathy [ Time Frame: 1 year ]
2) all-cause mortality, hospitalization for heart failure progression, stroke, heart transplantation
Same as current
Not Provided
Not Provided
 
Registry and Prevalence of Gene Mutation in Korean Patients With Familial Hypertrophic Cardiomyopathy
Not Provided
Set the Korean Familial Hypertrophic Cardiomyopathy (KFHC) registry to study the prevalence of gene mutations in Korean patients with familial hypertrophic cardiomyopathy
Not Provided
Observational [Patient Registry]
Observational Model: Cohort
Time Perspective: Prospective
2 Years
Retention:   Samples With DNA
Description:
serum, whole blood, DNA
Non-Probability Sample
familial hypertrophic cardiomyopathy patients and their relatives
Familial Hypertrophic Cardiomyopathy
Not Provided
familial hypertrophic cardiomyopathy
familial hypertrophic cardiomyopathy patients and their relatives
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
99
August 2013
August 2013   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  1. left ventricular maximal wall thickness ≥ 15mm on echocardiography
  2. hypertrophic cardiomyopathy patients' relatives

Exclusion Criteria:

  1. other cardiomyopathy or systemic disease (e.g. fabry disease, danon disease, glycogen storage disease)
  2. who deny the study entrance, especially in patients' relatives
Sexes Eligible for Study: All
13 Years and older   (Child, Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Korea, Republic of
 
 
NCT01792960
4-2012-0869
Yes
Not Provided
Not Provided
Yonsei University
Yonsei University
Not Provided
Not Provided
Yonsei University
February 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP